KŁUSEK, M.; CHAWRYLAK, K.; KUSZNERUK, J.; KUBAS, M.; KRZEMIŃSKA, K. Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review. Quality in Sport, [S. l.], v. 18, p. 53252, 2024. DOI: 10.12775/QS.2024.18.53252. Disponível em: https://apcz.umk.pl/QS/article/view/53252. Acesso em: 26 jul. 2024.